Showing results (421-430 of 587) with videos related to
Sort By:
Pageof 59
European Journal of Cancer (Oxford, England : 1990)|October 28, 2023
Clinical utility of plasma ctDNA sequencing in metastatic urothelial cancerClara Helal, Cédric Pobel, Arnaud Bayle, et al.ERJ Open Research|February 17, 2018
Real-life experience of ceritinib in crizotinib-pretreated ALK+ advanced non-small cell lung cancer patientsJacques Cadranel, Alexis B Cortot, Hervé Lena, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2017
Phase 2 Study of the HSP-90 Inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non-Small Cell Lung CancerEnriqueta Felip, Fabrice Barlesi, Benjamin Besse, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2022
Selpercatinib in Patients With RET Fusion-Positive Non-Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II TrialAlexander Drilon, Vivek Subbiah, Oliver Gautschi, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 24, 2018
Systemic Therapy in Advanced Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective CohortClaire Merveilleux du Vignaux, Eric Dansin, Laurent Mhanna, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2017
Nintedanib Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso TrialFederica Grosso, Nicola Steele, Silvia Novello, et al.Lung Cancer (Amsterdam, Netherlands)|August 21, 2009
A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancerGiorgio V Scagliotti, Paul Germonpré, Leon Bosquée, et al.Future Oncology (London, England)|December 30, 2025
The first United Arab Emirates expert consensus recommendations for the diagnosis and management of early and advanced non-small cell lung cancerHumaid Al Shamsi, Nadia Abdelwahed, Hassan Jaafar, et al.Nature Medicine|April 26, 2022
Digital remote monitoring plus usual care versus usual care in patients treated with oral anticancer agents: the randomized phase 3 CAPRI trialOlivier Mir, Marie Ferrua, Aude Fourcade, et al.European Journal of Cancer (Oxford, England : 1990)|June 21, 2021
Impact of COVID-19 on healthcare organisation and cancer outcomesAurelie Bardet, Alderic M Fraslin, Jamila Marghadi, et al.Pageof 59